• Explore /
  • Poster
  • / Real-world clinical efficacy of epidermal growth factor receptor inhibitors (EGFRi) in patients with early-onset (eo), metastatic colorectal cancer (mCRC).

Real-world clinical efficacy of epidermal growth factor receptor inhibitors (EGFRi) in patients with early-onset (eo), metastatic colorectal cancer (mCRC).

Abstract Poster

Authors

null

Hideaki Bando

Division of Drug and Diagnostic Development Promotion, Department for the Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East, Kashiwa, Japan

Hideaki Bando , Toshihiro Misumi , Harlan Pittell , Dionne Ng , Eri Tajima , Trevor Joseph Royce , Ivy Altomare , Prashni Paliwal , Yoshihiro Aoyagi , Kazuya Mizuguchi , Motoko Suzuki , Yuriko Takeda , Takayuki Yoshino , Atsushi Ohtsu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 36)

DOI

10.1200/JCO.2024.42.3_suppl.36

Abstract #

36

Poster Bd #

C17

Abstract Disclosures

Similar Posters

First Author: David Chan

First Author: Takenori Takahata

First Author: Maria C. Riesco Martinez

First Author: B. Chibaudel